Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Jill A. Henrich"'
Publikováno v:
Blood. 140:95-96
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::956cdd65347dcee07aac80d85d79e401
https://doi.org/10.1182/blood-2022-170165
https://doi.org/10.1182/blood-2022-170165
Autor:
Anilkumar Gopalakrishnapillai, Gerard McGeehan, Jill A Henrich, Haiming Xu, Yaniv Kazansky, Charlie Hatton, Emily B Heikamp, Sonali P. Barwe, Edward A. Kolb, Yanhe Wen, Alex Kentsis, Hannah Uckelmann, Eric M. Wong, Florian Perner, Scott A. Armstrong, Sumiko Takao, Yana Pikman
Publikováno v:
Blood. 139(6)
Translocations involving the NUP98 gene produce NUP98-fusion proteins and are associated with a poor prognosis in acute myeloid leukemia (AML). MLL1 is a molecular dependency in NUP98-fusion leukemia, and therefore we investigated the efficacy of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0faf476c4d84da68cea5a26b10f3094b
https://pubmed.ncbi.nlm.nih.gov/34582559
https://pubmed.ncbi.nlm.nih.gov/34582559
Autor:
Brandon J. Aubrey, Jevon A. Cutler, Wallace Bourgeois, Katherine A. Donovan, Shengqing Gu, Charlie Hatton, Sarah Perlee, Florian Perner, Homa Rahnamoun, Alexandra C. P. Theall, Jill A. Henrich, Qian Zhu, Radosław P. Nowak, Young Joon Kim, Salma Parvin, Anjali Cremer, Sarah Naomi Olsen, Nicholas A. Eleuteri, Yana Pikman, Gerard M. McGeehan, Kimberly Stegmaier, Anthony Letai, Eric S. Fischer, X. Shirley Liu, Scott A. Armstrong
Publikováno v:
Nature cancer. 3(5)
Acute myeloid leukemia (AML) remains difficult to treat and requires new therapeutic approaches. Potent inhibitors of the chromatin-associated protein MENIN have recently entered human clinical trials, opening new therapeutic opportunities for some g
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d42a2389125c850e48d6c7e0a7259c9
https://pubmed.ncbi.nlm.nih.gov/35624338
https://pubmed.ncbi.nlm.nih.gov/35624338